FDA Clearance Tracker · P970003-S106
VNS THERAPY SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 6, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Mar 6, 2009
Approved
Time to decision
29 days
Received Feb 5, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P970003-S106
- Device name
- VNS THERAPY SYSTEM
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- Feb 5, 2009
- Decided
- Mar 6, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CHANGING THE TRADE NAME OF THE VNS THERAPY PERENNIA MODEL 303 LEAD TO VNS THERAPY PERENNIADURA MODEL 303 LEAD.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.